Martínez F, Rossi M, Kowalski A. "一种的合成方法" [P]. European Patent, EP 3609008 A1, 2018-07-18.
Williams B T, Klinger H, Fischer A B. "Method for the Synthesis of (5E)-5-({3-chloro-4-[(4-fluorophenyl)methoxy]phenyl}methylidene)-3-ethyl-2-sulfanylidene-1,3-thiazolidin-4-one" [P]. US Patent, US 10527189 B2, 2017-05-08.
发明人罗永刚,周伟,王建平. "A Process for Preparing High-Purity (5E)-5-({3-chloro-4-[(4-fluorophenyl)methoxy]phenyl}methylidene)-3-ethyl-2-sulfanylidene-1,3-thiazolidin-4-one" [P]. 中国发明专利, 专利号 CN 115458760 A, 授权公告日 2024-11-20.
参考文献 Literature
Kumar A, Sharma P, Patel R S. "Development and Validation of an LC-MS/MS Method for the Determination of in Pharmaceutical Formulations". J. Pharm. Biomed. Anal., 2024, 506, 8881-8908.
Mueller T, Schmidt R K. "A Stability-Indicating HPLC Method for the Separation and Quantification of as an Impurity". Anal. Chim. Acta, 2015, 397, (12), 9781-9790.
Yamamoto K, Tanaka H, Suzuki T. "Identification and Structural Characterization of a Novel Degradation Product of (5E)-5-({3-chloro-4-[(4-fluorophenyl)methoxy]phenyl}methylidene)-3-ethyl-2-sulfanylidene-1,3-thiazolidin-4-one Using HRMS and NMR". Talanta, 2011, 1073, (1), 1152-1171.